GB2473813A

GB2473813A - Antibacterial zinc oxide (ZnO) nanoparticles doped with copper or magnesium

Info

Publication number: GB2473813A
Application number: GB0916202A
Authority: GB
Inventors: Vesna Alexandrovic; Charis Rabea Schlundt; Katja Werner; Marie Woost
Original assignee: Centrum fuer Angewandte Nanotechnologie CAN GmbH
Current assignee: Centrum fuer Angewandte Nanotechnologie CAN GmbH
Priority date: 2009-09-16
Filing date: 2009-09-16
Publication date: 2011-03-30
Also published as: WO2011033040A3; GB0916202D0; WO2011033040A2

Abstract

A method for the manufacture of colloidal ZnO particles doped with Cu or Mg comprises the steps of (i) dissolving salts of Zn and Cu or Mg in an alcoholic solution, preferably methanol or ethanol, to form a reaction mixture (ii) heating, preferably to a temperature of 60 to 65°C, and stirring the reaction mixture until a clear solution is formed (iii) adding a basic solution, preferably KOH in methanol, at room temperature drop by drop with vigorous stirring and (iv) heating the reaction mixture, preferably for at least 22 hrs at 60 to 65°C. Preferably the precursor salts of Zn, Cu and Mg are selected from zinc acetate, copper acetate and magnesium nitrate. The ZnO nanoparticles doped with Cu or Mg may be spherical or rod shaped and may be further bound to a polymer. The antibacterial ZnO/Cu and/or ZnO/Mg particles may be used in pharmaceuticals, cosmetics, medicines, disinfectants, antibacterial coatings or in the manufacture of textiles or fibres.

Description

INTELLECTUAL

. .... PROPERTY OFFICE Application No. GB09 16202.5 RTM Date:20 January 2010 The following terms are registered trademarks and should be read as such wherever they occur in this document: Cary Intellectual Property Office is an operating name of the Patent Office www.ipo.gov.uk

Description

Title: Antibacterial particles and their synthesis

FIELD OF THE TNVENTION

[0001] The field of the invention relates to a method for the manufacture of an antibacte-rial nanoparticle and its use.

BACKGROUND OF THE iNVENTION

[0002] It is well known that some kind of metallic nanoparticles, such as silver, copper and zinc, have antibacterial applications. Nanoparticles as antibacterial agents are relevant for many industrial sectors like environmental, healthcare, medical care, food, synthetic textiles etc.. ZnO nanoparticles due to their antibacterial characteristics and physical stabil-ity have been used as antibacterial material in textile industry, medicine, and cosmetics.

The antibacterial activity of the ZnO nanoparticles increases with decreasing nanoparticle size (Zhang, L et al., Journal of Nanoparticle Research 2007, 9, 479; Yamamoto, 0.; In-ternational Journal of Inorganic Materials 2001, 3, 643).

[0003] Copper as an antibacterial agent has been known for a long time. Copper ions (Cu2) are soluble in water and function at low concentration as bacteriostatic substances and fungicides. The copper can be used as an anti-germ surface that can add to the anti-bacterial and antimicrobial features of buildings, such as hospitals. The advantage of the copper is the low toxicity that is useful in antibacterial treatments. The syntheses of cooper nanoparticles is usually time consuming and very expensive, and often the particle ag-glomeration is a problem. In order to overcome these problems some groups used the deposition of the Cu on supporting substrates as, for example, silica glass or silica nanopar- tides (Y.H.Kim, D.K. Lee, J Phys. Chem. B, 2006, 110, 24923; C.C. Trapalis, M. Kokko-ris, G. Perdikakis, G. Kordas J. Sol-Gel Sei. Tech. 2003 26 1213), or by using chitosan (composite film -G.Cardenas, J. Diaz, M.F. Melendrez Polym Bull 2009, online 08 Janu-ary; Wen-Li Du, Ying -Lei Xu Nanotechno logy, 2008, 19 085707 page 5), or sepiolite (J Mater Sei 2006 41 5208) as a carrying materials for Cu nanoparticles.

[0004] The US Patent Application Number US 2006/0222586 Al discloses the syntheses of ZnO nanoparticles smaller or equal to 15 nm, starting with zinc chloride or zinc chloride hydrate and an inorganic alkali, both dissolved in ethylene glycol. Afterwards the precipi-tated ZnO particles are thermally aged.

[0005] In the US Patent Application Number US 2005/0260122 Al a sol-gel method is described, wherein a metal oxide precursor and an alcohol based solution are mixed to form a reaction mixture that is then allowed to react in order to produce a metal oxide nanoparticle. During synthesis the pH conditions have to be carefully controlled to main-tam a pH of about 7 or higher.

[0006] The antibacterial activity of the ZnO nanoparticles is described in an article by Zhang et al. (Zhang, Let al Journal of Nanoparticle Research 2007, 9, 479) where the au-thors come to the conclusion that ZnO nanofluids as a bacteriostatic active agent against E.coli are suitable with a concentration above 0.25 g/l. The antibacterial activity increases with increasing nanoparticle concentrations and decreasing nanoparticle size. Additionally, the authors claim that the presence of polyethylene glycol and polyvinylpyrolidone does not affect the antibacterial activity of ZnO nano fluids.

[0007] The antibacterial activity of ZnO against E. coli and additionally against S. aureus is further described by Yamamoto (Yamamoto, 0.; International journal of Inorganic Ma- terials 2001, 3, 643) .The author also describe that the antibacterial activity of ZnO in-creases with a decrease of particle size and increase of powder concentration.

[0008] In addition to the results of Yamamoto, Reddy et al. (K. M. Reddy, Kevin Feris, Jason Bell, Denise G. Wingett, and Cory Hanley, Alex Punnoose, Applied physics letters 2007, 90, 213902) report the toxicity of ZnO nanoparticles to gram-negative and gram-positive bacterial systems, Escherichia coli (E. coli) and Staphylococcus aureus (S.

aureus), and primary human immune cells. ZnO nanoparticles with a diameter of 13 nm showed a complete inhibition of E. coli growth at concentrations of 3.4 mIVI, whereas growth of S. aureus was completely inhibited with 1 mM of nanoparticles.

[0009] The specific role of size scale, surface capping, and the aspect ratio of ZnO nanoparticles on toxicity toward prokaryotic and eukaryotic cells is reported by Shantiku- mar and colleagues (Shantikumar et al., J.Mater.Sei.Mater.Med. 2008). The authors inves- tigated nanoparticles having a diameter of 40 nm, 150 nm and 350 nm. The ZnO nanopar- tides that were PEG-capped were increasingly antibacterial in nature as the size was re- duced from the micro-scale to the nano-scale and at increasing concentrations. The anti-bacterial activity was less towards Gram-positive bacteria than towards Gram-negative bacteria, but the functional dependence on particle size was the same. In contrary, starch capping of the nanoparticles appeared to provide greater protection to bacteria, possibly due to the OH-related quenching of positive charges on the ZnO nanoparticle surface.

[0010] The antibacterial activity of MgO nanoparticles synthesised by microwave-assisted synthesis were tested against E. coli and S. aureus by Makhluf and colleagues (Makhluf et al., Adv. Funct.lMater. 2005, 15, 1708). The authors used a solution with a concentration of about 1 mg/ml and demonstrated that the antibacterial activity of the MgO nanoparticles depends strongly on their particle size.

[0011] The preparation of ZnO/Mg nanoparticles is described by Huan-Ming et al. (Huan-Ming et al, Angewandte Chemie International EditionL 2009, 48, 15, 2727 starting from the previously synthesized ZnO nanoparticles and afterwards applying sonication procedure in the presence of magnesium acetate tetra hydrate. The particles were not syn-thesized starting from precursor for Zn and Mg.

[0012] International Patent Application W02008043396 discloses all materials based on colloidal silica, titanium dioxide, zirconium dioxide, stannic dioxide and zinc oxide, con-nected trough organic ligands with metal ions as antibacterial and antimycotic materials.

WO 2008/043396 does not describe incorporation of metal ions in the nanoparticle or di-rectly on the nanoparticle surface.

[0013] None of the prior art discloses a simple method for the manufacture of ZnO parti- cles doped with copper or magnesium as disclosed herein for the manufacture of new anti-bacterial material with low toxicity and higher antibacterial effect than ZnO particles.

BRIEF SUMMARY OF THE INVENTION

[0014] The present disclosure provides a method for the synthesis of antibacterial nanoparticles based on ZnO doped with copper or magnesium, and investigation of their antibacterial activity on Escherichia Coli (E.Coli) DH5ct as a representative of gram- negative bacteria and Staphylococcus Carnosus (S. Carnosus) as a representative of gram-positive bacteria.

[0015] The present disclosure teaches the synthesis of ZnO particles by a wet procedure in methanol as a reaction media, and during the syntheses, the ZnO particles were doped with various amount of copper or magnesium. The shape of the particles was varied from spherical via rise-shape to elongated, rod like particles. The particle size varied from a few nano metres up to 100 nm.

[0016] Antibacterial tests with Escherichia Coli (E.Coli) DH5ct and Staphylococcus Car-nosus (S. Carnosus) bacteria confirmed the higher antibacterial activity of the doped ZnO particles than the pure ZnO nanoparticles. The antibacterial activity was demonstrated for both types of nanoparticles, doped with Cu or Mg. Additionally, it was found that antibac-terial activity is strongly dependent on concentration of doped elements in the ZnO nanoparticles.

DETAILED DESCRIPTION OF THE INVENTION

[0017] The invention provides a method for the manufacture of colloidal ZnO particles doped with Cu or Mg comprising: a. dissolving salts of Zn and Cu or Mg in an alcoholic solution to form a reac-tion mixture; b. heating and stirring the reaction mixture until a clear solution is formed c. adding a basic solution at room temperature drop by drop under vigorous stirring d. heating the reaction mixture.

[0018] As precursor Zn(Ac)2 x 2H20 and Cu(Ac)2 x H20 or Mg(N03)2 x 6H20 can be used. Prior to heating the reaction mixture a solution of Cu(Ac)2 x H20 dissolved in an al-cohol at room temperature can be injected. It is further intended to use 0.5 to 15 mol % of copper precursor calculated on the amount of Zn(Ac)2.

[0019] The alcoholic solution used in the disclosed method comprises methanol or etha- nol as solvent. It is also within the scope of the invention that the alcoholic solution com- prises other solvents, for instance water. The basic solution comprises a solution of an al-kali in an alcoholic solution, for example methanol. Within the meaning of the disclosed method the term "alkali" shall be understood as alkali metal or earth alkali metal hydroxide and a basic solution shall be a solution comprising an alkali, like the basic solution of KOH or Ba(OH)2.

[0020] The reaction mixture of the Zn and Cu or Mg salts may be heated to a temperature in the range of 60 to 65°C and the final heating of the reaction mixture can be done for at least 22 h at 64°C.

[0021] The size and/or shape of the resulting particles may be adjusted by the amount of copper or magnesium precursor, since there is a dependency between these parameters.

[0022] It is further intended that he ZnO particles may be doped with Cu or Mg that is bound to a polymer.

[0023] A further object of the invention is a particle consisting of ZnO doped with cop-per. The size of such a particle may be in the range of 3 to 10 nm for spherical particles and 3 mm in one dimension and up to 100 nm in the other dimension for rod like shaped particles.

[0024] The disclosed particle shall comprise up to 3% of incorporated copper.

[0025] Another object of the disclosure of this invention is an antibacterial composition comprising ZnO/Cu and /or ZnO/Mg particles manufactured according to one of the dis-closed methods above. Such a composition may be a pharmaceutical, cosmetic or medicine product.

[0026] The disclosed particles and the composition may be further used as disinfectant, antibacterial coating or as an additive in cosmetic, medicine or pharmaceutical products.

[0027] It is also intended that the disclosed particles may be used for the manufacture of textiles or fibres for the manufacture of textiles with antibacterial properties.

[0028] The syntheses of the nanoparticles based on ZnO doped with cooper or magne- sium is performed by a wet procedure in methanol as reaction media, starting form differ-ent salts of Zn and Cu or Mg as a precursor. Mixture of the different salts added in certain ratios was stirred at 64°C until a clear solution was formed. Then a solution of alkali in methanol was added drop by drop at room temperature under vigorous stirring. Formed nanoparticles were heated for a minimum of22 hours at 64°C. Particle size was varied from few nanometres up to 100 nm. Additionally, shape of the particles was varied from spheri- cal via rise-shape until elongated, rod like particles by changing a precursor ratio in reac-tion mixture.

BRIEF DESCRIPTION OF THE FIGURES

[0029] The invention will be further described by figures and examples without being limited to the described embodiments: Fig. 1 influence of Cu concentration in starting reaction mixture on nanoparticle size Fig. 2 TEM images of ZnO/Cu nanoparticles synthesized a) with 10% Cu(Ac)2; b) with 0.5% Cu(Ac)2 (after 22 h heating at 64 °C) Fig. 3 XRD patterns of ZnO/Cu nanoparticles synthesized with A -10 % Cu(Ac)2 and B with 0.5 % Cu(Ac)2 Fig.4 Emission bands of ZnO/Cu nanoparticles synthesized with A -10 % Cu(Ac)2 and B -0.5 %Cu(Ac)2 Fig. 5 Growth curves of E.Coli in LB medium inoculated in the presence of ZnO/Cu (Cu-3%) nanoparticles at different concentrations and of ZnO (ZnO-RZO1) nanoparticles.

Fig. 6 Growth curves of S.Carnosus in LB medium inoculated in the pres-ence of ZnO/Cu (Cu-3%) nanoparticles at different concentrations and of ZnO (ZnO-RZO 1) nanoparticles.

Fig. 7 Growth curves of E.Coli in LB medium inoculated in the presence of ZnO/Mg (Mg-1%)) nanoparticles at different concentrations and in the presence of ZnO/Cu (Cu-2%) nanoparticles.

Fig.8 Growth curves of E.Coli in LB medium inoculated in the presence of ZnO/Cu nanoparticles with different copper percentages and in the presence of ZnO nanoparticles Fig. 9 SEM images of E.Coli: (a) E.Coli before treatment; (b) E,Coli after treatment with ZnO/Cu (Cu-3%) at 1.5 mg/niL for 4h).

DETAILED DESCRIPTION OF THE INVENTION

Synthesis of ZnO/Cu colloid nanoparticles [0030] High quality crystalline copper doped ZnO nanoparticles were synthesized by procedures as described in the examples below. The shape of the synthesized ZnO/Cu nanoparticles can be controlled from spheres to rods, depending on the copper precursor concentration and on the time of a copper precursor addition. The formation of ZnO/Cu rods is based on an oriented attachment of preformed quasi-spherical nanoparticles. The length of nanoparticles synthesized with different copper concentrations is shown in Figure 1. The nanoparticles were heated at 64 °C for 22 hours.

[0031] The length of the rods decreases with the copper concentration until a concentra-tion limit (1.5 mol %) is reached, where the oriented attachment of semi-spherical particles formed at the beginning is avoided. If the Cu(Ac)2 amount exceeds 1.5 mol % calculated on amount of Zn(Ac)2, the formed the ZnO/Cu nanoparticles have a spherical shape. By usage of higher amount of copper precursors than the 1.5 mol % the nanoparticles became smaller and spherical. Two typical samples of nanoparticles synthesized starting from 10 and 0.5 mol % of copper precursor are shown in the TEM images in Fig 2.

[0032] The crystallinity of the synthesized nanoparticles was checked using X-ray dif- fractometry. The typical powder X-ray diffractogram is shown at Figure 3. The measure-ments show that the nanoparticles have a crystalline structure that is typical for Wurtzite type of ZnO. Using Scherer line it was calculated for the nanoparticles synthesised with 10 % Cu(Ac)2 that their average nanoparticle diameter is around 5 nm. This calculation is in very good agreement with the TEM images (Figure 2.) [0033] A decrease of the copper concentration leads to an increase of the elongation of the nanoparticles along the c axis. With a 0.5 % copper precursor, the nanoparticles are rods with a length of 30 nm and a diameter of 8 nm -calculated based on TEM image (Figure 2 (b)). The rod formation along the c axis was confirmed by XRD diffractogram (Fig. 3 (b)) that shows much sharper 002 reflection than the other reflections. Characteris- tic peaks for CuO was not found at XRD patterns, thus it can be supposed that copper at-oms replace zinc in the hexagonal lattice and/or copper segregate to the non-crystalline region probably on the nanoparticle surface.

[0034] Conformation of Cu atoms incorporation into the nanoparticles was obtained by measurement of the room temperature photoluminescence (PL). The room temperature photoluminescence (PL) of the ZnO nanostructures typically exhibits a sharp emission band in near IJY range (originating from the exciton recombination ER) and a broad emis- sion band in the visible region of the spectrum (so called green emission GE) that is attrib- uted to defects in ZnO like vacancies of zinc or oxygen. Since the ZnO nanoparticles ex- hibit different types of defects, the emission in the visible region remains difficult to iden-tify.

[0035] The photoluminescence spectrum of the ZnO/Cu nanoparticles in chloroform syn- thesized with 0.5 and 10 % of the copper precursors are shown in Figure 4. The PL spec- trum exhibits the typically sharp emission in near UV of ZnO material. However the inten-sity of the green emission depends strongly on the copper precursor concentration used during the synthesis of the ZnO/Cu nanostructures. The intensity ratio (Intensity of ER / Intensity of GE) obtained form the spectra is presented in table 1.

[0036] The more copper precursors used for the synthesis, the weaker the intensity of the peak. For a concentration of copper precursor larger than S %, the green emission was quenched. Therefore it can be supposed that the copper atoms fill the states corresponding to the defects in ZnO.

[0037] Amount of Cu atoms present in synthesized nanoparticles was determined by en-ergy-dispersive X-ray analysis (EDX). The obtained results are summarized in table 1.

Amount of Ou in Shape of Synthesis reaction mixture nanoparticles Sze PL Intensity ratio %Cu (ED/K) diameter! length ______________ ______________ ______________ (on) ______________ ______________ Cu-a 0,50 rods 8/30 1/7 Cu-b I rods 8120 1/4 -Cu-c 1.5 rods 8/11 1/1 Cu-d 2 rica 5/9 1/0,5 0,50% Cu-e 3 dots 3 1/0,4 0,30% Cu-2% 5 dots I no green omission 2% Cu-3% 10 dots 5 no green emission 3% Cu-4% 15 dots 5 no green omiscion Table 1: Influence of the amount of Cu precursor in reaction mixture on ZnO/Cu nanopar-tide shape, size and photoluminescence (PL).

[0038] In all of the samples Cu was detected except in the sample Cu-a synthesized with 0.5 % copper precursor. However the intensity of the green emission of Cu-a measured by PL remained lower than the intensity of the pure ZnO nanoparticles, which implies that some of the copper ions are incorporated into the nanoparticles.

Antibacterial study [0039] The bacteria used for the antibacterial study were E. Coil DHSct, Gram-negative and S. Carnosus TM300. S. Carnosus as a typical gram-positive bacterium. Antibacterial tests were performed with a solution of nanoparticles in distilled water.

[0040] The ZnO/Cu nanoparticles synthesized with 15 %, 10 % and 5 % of the copper precursor were used for the antibacterial study. The average size of the ZnO/Cu nanoparti-des was from 7 to 5 nm and the fraction of the copper (in mol) ranges from 2 to 4 %. The ZnO nanoparticles synthesized according to the method of Pacholsky et al. (C. Pachoiski, A. Komowski, H. Weller Angew. Chem 2002 114 7 1234). was used as comparison. Their average size was 7 nm that is in the same range as investigated ZnO/Cu nanoparticles.

Effect of the nanoparticle concentration on antibacterial properties [0041] E. Co/i and S. Carnosus bacteria were tested with different concentrations of the nanoparticles in order to observe the effect of nanoparticle concentration on bacterial growth. The final concentration of the ZnO and ZnO/Cu nanoparticles in the bacterial cul- tures ranged from 0.300 to 0.070 mg/ml. As the control, samples were used the same sol-vent as for the nanoparticles and LB medium.

[0042] The growth curves of the E.Coli DH5u and S. Carnosus TM300 bacteria are shown on Figure 5 and 6, respectively. The bacteria growth was determined by measuring the time evolution of the optical density (OD) of the sample at 600 nm. As the value of the OD at 600 nm represents the absorbance of the bacteria, an increase of the number of the bacteria implies more light being absorbed by the bacteria.

[0043] As expected the control sample containing the solvent showed no antibacterial activity. The results shows in Fig.6 indicate an increase of the antibacterial activity with increase of the nanoparticle concentration in the medium. The ZnO/Cu nanoparticles con-taining 3% copper are antibacterial against the E. Co/i bacteria above a concentration of 0.09 mg/mi whiie the ZnO nanoparticies show the antibacteriai effect oniy above 0.13 mg/ml. similar results was obtained with S. Carnosus (Figure 6.). Thus the results demon-strate that the ZnO/Cu nanoparticles have a higher antibacterial activity than the ZnO nanoparticles.

The same investigations were done with the ZnO nanoparticles doped with Mg. The growth curves of E.Coii DH5a inoculated with the ZnO/Mg nanoparticles that contain 1% of Mg were shown in Figure 7. The ZnO/Mg nanoparticles with 1% of Mg show the anti- bacterial activity against E.Coii bacteria above a concentration of 0.07 mg/ml, that mdi-cates higher antibacterial effect of ZnO/Mg nanoparticles than pure ZnO nanoparticles.

Effect of the copper percentage in the ZnO/Cu nanoparticles on antibacterial properties [0044] A series of experiments was done with the ZnO/Cu nanoparticles that contain dif- ferent percentages of Cu. The nanoparticles were investigated in the same way as was pre-viously described. The growth curve of E. Coil bacteria inoculated with the ZnO/Cu nanoparticles containing copper percentages from 2, 3 and 4 % are shown in Figure 8.

[0045] The results indicate a small increase in the antibacterial activity of the ZnO/Cu nanoparticles with a decrease of the copper percentage. All of the ZnO/Cu nanoparticles show the antibacterial activity against the E. Co/i bacteria above a concentration of 0.09 mg/mi, which remains higher than the antibacterial activity of the ZnO nanoparticles.

SEM analysis of the E.Coii bacteria [0046] The antibacterial effect of the ZnO/Cu nanoparticles against the E. Co/i bacteria was directly confirmed by scanning electron miscopy (SEM) of the E. Co/i bacteria before and after exposure to the nanoparticles (Figure 9). Figure 9 shows normal E.Coii bacteria and E. Co/i bacteria after a treatment with the ZnO/Cu nanoparticles containing 3% copper at a concentration of 1.5 mg/ml for 4 hours, respectively. The images indicate that the presence of the ZnO/Cu nanoparticles leads to the damages of membrane wall of the E. Coil bacteria.

[0047] Investigations of the synthesized ZnO/Cu nanoparticles and the synthesized ZnO/Mg nanoparticles on polystyrol plates also showed a higher antibacterial effect than the pure ZnO nanoparticles. These results indicate possible future application of synthe-sized nanoparticles not only in cosmetic or medicine but additionally in all areas where antibacterial coating are required. Any other commercial polymer surface may be suitable like for example polyethylene, polypropylene, PVC etc.

EXAMPLES

Syntheses of nanoparticles [0048] Colloidal ZnO/Cu nanoparticles and ZnO/Mg nanoparticles were synthesized from zinc acetate dehydrate (Zn(Ac)2 x 2H20) with copper acetate monohydrate (Cu(Ac)2 x H20) and magnesium nitrate (Mg(N03)2 x 6 H20) hexahydrate, respectively, in an alco- hol solution under basic conditions. The synthesis is a modification of the method devel-oped by Pacholsky et al. (C. Pacholski, A. Kornowski, H. Weller Angew. Chem. 2002 114 7 1234). The shape and size of the colloidal nanoparticles was varied from spheres to rods depending on the concentration of copper precursor in reaction mixture.

[0049] Example 1: 3.0 g of Zn(Ac)2 x 2H20 and 0.27 g of Cu(Ac)2 x H20 were dissolved in 18 ml of methanol to form a reaction mixture. The reaction mixture was heated at 64°C in a three-neck flask until a clear solution was formed. To produce the nanoparticles, a solution of 1.5 g of KOH dissolved in 6.5 ml of methanol at room temperature was added drop by drop into the three-neck flask under vigorous stirring. After the addition the reac-tion mixture was heated for minimum 22 hours at 64°C.

[0050] Example 2: 3.0 g of Zn(Ac)2 x 2H20 and 0.4 g of Cu(Ac)2 x H20 were dissolved in 18 ml of methanol to form a reaction mixture. The reaction mixture was heated to 64°C in a three-neck flask until a clear solution was formed. To produce the nanoparticles, a solution of 1.5 g of KOH dissolved in 6.5 ml of methanol at room temperature was added drop by drop into the three-neck flask under vigorous stirring. After the addition the reac-tion mixture was heated for minimum 22 hours at 64°C.

[0051] Example 3: 3.0 g of Zn(Ac)2 x 2H20 was dissolved in 18 ml of methanol to form a reaction mixture. The reaction mixture was heated to 64°C in a three-neck flask until a clear solution was formed. A solution of 1.5 g of KOH dissolved in 6.5 ml of methanol at room temperature was added drop by drop into the three-neck flask under vigorous stirring.

After 1.5 hours a Solution of 0.27 g of Cu(Ac)2 x H20 dissolved in 7.5 ml methanol at room temperature was injected into the three-neck flask. After the injection the reaction mixture was heated for minimum 22 hours at 64°C.

[0052] Example 4: 3.0 g of Zn(Ac)2 x 2H20 and 0.36 g of Mg(N03)2 x 6H20 were dis-solved in 18 mL of methanol to form a reaction mixture. The reaction mixture was heated to 64°C in a three-neck flask until a clear solution was formed. To produce the nanoparti-cless, a solution of 1.5 g of KOH dissolved in 6.5 mL of methanol at room temperature was added drop by drop into the three-neck flask under vigorous stirring. After the addition the reaction mixture was heated for minimum 22 hours at 64°C.

[0053] Example 5: 3.0 g of Zn(Ac)2 x 2H20 and 0.14 g of MgC12 were dissolved in 18 mL of methanol to form a reaction mixture. The reaction mixture was heated to 64°C in a three-neck flask until a clear solution was formed. To produce the nanoparticles, a solution of 1.5 g of KOH dissolved in 6.5 mL of methanol at room temperature was added drop by drop into the three-neck flask under vigorous stirring. After the addition the reaction mix-ture was heated for minimum 22 hours at 64°C.

[0054] US Patent US 6710091 Bl discloses the synthesis of ZnO nanoparticles having an average particle diameter of less than or equal to 15 nm, which are redispersible in or-ganic solvents and/or water by basic hydrolysis of at least one Zn-compound in alcohol or an alcohol/water mixture. US 6,710,091 does not disclose the synthesis of larger particles, or rods, and no doping of the ZnO nanoparticles with other metals.

Characterization of nanoparticles [0055] The synthesized nanoparticles were characterized by low and high-resolution transmission electron microscopy (TEM), electron diffraction, and X-ray diffraction. TEM samples were prepared by dropping diluted aqueous solutions of the ZnO/Cu nanoparticles onto 400-mesh carbon-coated copper grids with excess solvent immediately evaporated.

[0056] The optical properties of the nanoparticles have been characterized by electronic absorption and fluorescence spectroscopy. Absorption spectra were obtained using a Cary spectrophotometer. Photoluminescence measurements were performed at room tem-perature using a Cary 50 spectrofluorimeter.

Tests of antibacterial activity [0057] Escherichia Coli (E.Coli) DH5a and Staphylococcus Carnosus (S. Carnosus) TM300 bacteria were used for the antibacterial tests. The bacteria were cultured in an LB medium at 37°C on a shaker. The bacterial culture was suspended in a sterile LB medium at a final concentration of approximately i07 CFU cm"3 (CFU:Colony Forming Unit) and used for the bacterial assays.

[0058] The antibacterial activity of the nanoparticles was assessed by measuring the growth curve of the bacteria. 1.5 ml of the ZnO/Cu nanoparticles solution was diluted in 14.7 ml LB medium with 300 tl bacteria. The bacterial cultures incubated with the nanoparticles were grown at 37°C under an agitation condition. The growth curve was de-termined by measuring the time evolution of the optical density (OD) of the sample at 600 nm. A blank LB broth medium culture under the same conditions was used as a control.

Claims

Claims 1. A method for the manufacture of colloidal ZnO particles doped with Cu or Mg comprising: -dissolving salts of Zn and Cu or Mg in an alcoholic solution to form a reac-tion mixture; -heating and stirring the reaction mixture until a clear solution is formed -adding a basic solution at room temperature drop by drop under vigorous stirring -heating the reaction mixture.
2. The method according to claim 1, wherein Zn(Ac)2 x 2H20 and Cu(Ac)2 x H20 or Mg(N03)2 x 6H20 are used as a precursor.
3. The method according to one of the above claims, further comprising for the manu- facture of ZnO particles doped with Cu injecting a solution of Cu(Ac)2 x H20 dis-solved in an alcohol at room temperature prior to heating the reaction mixture.
4. The method according to one of the above claims, wherein 0.5 to 15 mol % of cop-per precursor calculated on the amount of Zn(Ac)2 are used.
5. The method according to one of the above claims, wherein the alcoholic solution comprises methanol or ethanol as solvent
6. The method according to one of the above claims, wherein the basic solution com-prises the solution of an alkali in methanol.
7. The method according to one of the above claims, wherein the alkali in the basic solution is KOH.
8. The method according to one of the above claims, wherein the reaction mixture of the Zn and Cu or Mg salts is heated to a temperature in the range of 60 to 65°C.
9. The method according to one of the above claims, wherein the final heating of the reaction mixture is done for at least 22 h in the range of 60 to 65°C.
10. The method according to one of the above claims, wherein the size and/or shape of the resulting particles is dependent on the amount of copper or magnesium precur-sor.
11. The method according to one of the above claims, wherein the ZnO particles doped with Cu or Mg are bound to a polymer.
12. A particle consisting of ZnO doped with copper.
13. The particle of claim 12, with a size of 3 to 10 nm for spherical particles and 3 mm in one dimension and up to 100 nm iii the other dimension for rod like shaped par-ticles.
14. The particle of claim 12 or 13, comprising up to 3% incorporated copper or 1% in-corporated magnesium.
15. An antibacterial composition comprising ZnO/Cu and /or ZnO/Mg particles manu-factured according to one of the methods of claims ito 11.
16. The composition according to claim 15, wherein the composition is a pharmaceuti-cal, cosmetic or medicine product.
17. Use of the particle according to any of the claims 12 to 14, or the composition ac-cording to claim 14 or 15 as disinfectant.
18. Use of the particle according to any of the claims 12 to 14 or the composition ac-cording to claim 14 or 15 as antibacterial coating.
19. Use of the particle according to any of the claims 12 to 14 or the composition ac- cording to claim 14 or 15 as additive in cosmetic, medicine, pharmaceutical prod-ucts.
20. Use of the particle according to any of the claims 12 to 14 or the composition ac- cording to claim 14 or 15 for the manufacture of textiles or fibres for the manufac-ture of textiles with antibacterial properties.